Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 14, 2023; 29(6): 1054-1075
Published online Feb 14, 2023. doi: 10.3748/wjg.v29.i6.1054
Published online Feb 14, 2023. doi: 10.3748/wjg.v29.i6.1054
Figure 4 Schematic representation of T cell receptor engineered T cells and chimeric antigen receptors (CAR) engineered T cells in hepatocellular carcinoma.
AFP: Alpha-fetoprotein; CAR-T: Chimeric antigen receptors engineered T cell; MAGE: Melanoma-associated antigen; MHC: Major histocompatibility complex; TAA: Tumor-associated antigens; TCR: T cell receptor.
- Citation: Mandlik DS, Mandlik SK, Choudhary HB. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World J Gastroenterol 2023; 29(6): 1054-1075
- URL: https://www.wjgnet.com/1007-9327/full/v29/i6/1054.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i6.1054